Dai Bojie, Zhao X Frank, Hagner Patrick, Shapiro Paul, Mazan-Mamczarz Krystyna, Zhao Shuchun, Natkunam Yasodha, Gartenhaus Ronald B
University of Maryland Greenebaum Cancer Center, Baltimore, MD 21201, USA.
Cancer Res. 2009 Oct 1;69(19):7835-43. doi: 10.1158/0008-5472.CAN-09-1606. Epub 2009 Sep 29.
The MCT-1 oncogene was originally identified from lymphoma cell lines. Herein we establish that MCT-1 is highly expressed in 85% of human diffuse large B-cell lymphomas (DLBCL) and that knocking down MCT-1 by a specific short hairpin RNA in DLBCL cells induces apoptosis, supporting a critical role for MCT-1 in DLBCL cell survival. However, the mechanism underlying MCT-1 regulation is largely unknown. We find that MCT-1 is phosphorylated and up-regulated by extracellular signal-regulated kinase (ERK). Furthermore, by using a small inhibitory molecule targeting ERK, we interrupted MCT-1 phosphorylation and stability. Significantly, cells with distinct levels of MCT-1 protein displayed differential sensitivity to ERK inhibitor-induced apoptosis. Treatment with the ERK inhibitor showed marked in vivo antitumor activity in a human DLBCL xenograft model. Our findings establish a functional molecular interaction between MCT-1 and the MEK/ERK signaling pathway and suggest that the activation of MCT-1 function by its upstream kinase ERK plays an important role in lymphomagenesis.
MCT-1癌基因最初是从淋巴瘤细胞系中鉴定出来的。在此我们证实,MCT-1在85%的人类弥漫性大B细胞淋巴瘤(DLBCL)中高表达,并且在DLBCL细胞中通过特异性短发夹RNA敲低MCT-1可诱导细胞凋亡,这支持了MCT-1在DLBCL细胞存活中起关键作用。然而,MCT-1调控的潜在机制在很大程度上尚不清楚。我们发现MCT-1被细胞外信号调节激酶(ERK)磷酸化并上调。此外,通过使用靶向ERK的小分子抑制剂,我们阻断了MCT-1的磷酸化和稳定性。值得注意的是,具有不同MCT-1蛋白水平的细胞对ERK抑制剂诱导的细胞凋亡表现出不同的敏感性。在人DLBCL异种移植模型中,ERK抑制剂治疗显示出显著的体内抗肿瘤活性。我们的研究结果建立了MCT-1与MEK/ERK信号通路之间的功能性分子相互作用,并表明其上游激酶ERK对MCT-1功能的激活在淋巴瘤发生中起重要作用。